Follow-The-Filings

DME Capital Management, LP

13F holdings history for

GANX · Gain Therapeutics Inc.

Ticker
GANX
Investment type
Equity
Class
COM
Manager
David Einhorn - DME Capital Management

Shares held by quarter

New Add Reduce Exit

  1. 2024 Q1 · 566,130 shares · $2M · 0.10% of portfolio
  2. 2024 Q2 · 566,130 shares · $725K · 0.04% of portfolio
  3. 2024 Q3 · 566,130 shares · $1M · 0.04% of portfolio
  4. 2024 Q4 · 566,130 shares · $1M · 0.06% of portfolio
  5. 2025 Q1 · 566,130 shares · $1M · 0.05% of portfolio
  6. 2025 Q2 · 566,130 shares · $1M · 0.04% of portfolio
  7. 2025 Q3 · 566,130 shares · $1M · 0.04% of portfolio
  8. 2025 Q4 · 566,130 shares · $2M · 0.06% of portfolio
  9. 2026 Q1 · 566,130 shares · $1M · 0.03% of portfolio
  10. 2026 Q2 · 566,130 shares · $1M · 0.03% of portfolio
Holdings date Value % of holdings Shares Filing date All 13F holders